FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings - FORCE study
FYB-201 雷珠单抗生物类似药(Ongavia/Ranivisio/Cimerli)在临床环境中的疗效和安全性 - FORCE 研究
期刊:
影响因子:
doi:10.1038/s41433-025-04030-7
Sharma, Ashish; Nicholson, Luke; Vazquez-Alfageme, Clara; Sivagnanavel, Vasuki; Fausto, Riccardo; Soare, Maria Cristina; Salamanca, Marta Bautista; Fabozzi, Lorenzo; Tsika, Chrysanthi; Corbalan, Olga Cejudo; Verdejo, Alejandro Gomez; Wakabayashi, Taku; Woo, Se Joon; Kolomeyer, Anton M; Mansour, Hana; Momenaei, Bita; Regillo, Carl D